Cas9 Expressing Human breast adenocarcinoma cells

SK-BR-3-CAS9 is a genetically engineered cell line derived from the SK-BR-3 breast cancer cell line modified with a CRISPR-Cas9 system to enable precise genome editing capabilities This product is particularly valuable for researchers investigating oncogenic mechanisms drug resistance and therapeutic interventions in breast cancer The CRISPR-Cas9 technology utilizes a guide RNA to direct the Cas9 nuclease to specific genomic loci allowing for targeted modifications such as gene knockout or insertion This facilitates the study of gene function and the identification of potential therapeutic targets with high specificity and efficiency

The scientific importance of SK-BR-3-CAS9 lies in its application in functional genomics and cancer research By providing researchers with a reliable tool for gene editing SK-BR-3-CAS9 can be employed to study the effects of various genetic alterations on tumorigenesis cell proliferation and response to treatment This capability makes it a crucial asset for developing novel therapeutics and understanding the molecular drivers of breast cancer

Compared to traditional methods of genome editing such as zinc finger nucleases or TALENs the SK-BR-3-CAS9 provides several advantages including ease of use higher precision and a reduced off-target effect Additionally its compatibility with high-throughput screening approaches allows for large-scale systematic studies increasing the throughput of research efforts

Researchers and clinicians alike will find SK-BR-3-CAS9 invaluable for its unique ability to elucidate complex interactions within cancer biology leading to groundbreaking discoveries and improved treatment modalities Our company specializes in the development and delivery of innovative biological products aimed at enhancing research efficacy and therapeutic development ensuring that you have access to the most advanced tools available